Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
10.70
-0.54 (-4.80%)
At close: Apr 14, 2026, 4:00 PM EDT
11.07
+0.37 (3.42%)
After-hours: Apr 14, 2026, 6:56 PM EDT

Telix Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
141.8744083.9579.1616.02
Cash & Short-Term Investments
141.8744083.9579.1616.02
Cash Growth
-67.76%424.12%6.05%394.22%-73.31%
Accounts Receivable
129.286.9344.1326.7814.12
Inventory
37.0823.6211.795.772.51
Other Current Assets
22.1319.5718.526.171.91
Total Current Assets
330.28570.12158.39117.8934.56
Net Property, Plant & Equipment
115.6133.6520.7712.824.6
Other Intangible Assets
592.82257.8674.740.1440.51
Long-Term Investments
37.0934.758.35--
Other Long-Term Assets
88.1844.0114.332.920.15
Total Assets
1,164940.38276.54173.7779.82
Accounts Payable
150.3586.7955.6633.713.84
Accrued Expenses
50.1144.2322.5310.123.46
Current Portion of Long-Term Debt
13.1111.760.66-0.01
Current Portion of Leases
5.551.550.410.440.45
Unearned Revenue
0.46.977.493.364.47
Other Current Liabilities
12.153.7925.710.615.38
Total Current Liabilities
231.62205.09112.4458.2227.61
Long-Term Debt
391.91341.815.592.25-
Long-Term Leases
56.535.045.234.421.39
Other Long-Term Liabilities
68.5435.551.8454.4349.26
Total Long-Term Liabilities
516.99382.3562.6661.150.64
Total Liabilities
748.61587.44175.1119.3278.25
Common Stock
479.96414.01304252.45124.18
Additional Paid-in Capital
-11.6115.95-42.8-11.974.32
Accumulated Other Comprehensive Income
101.5675.8919.85-0.38-0.84
Retained Earnings
-154.54-152.91-179.61-185.65-126.09
Shareholders' Equity
415.38352.94101.4454.441.57
Total Liabilities & Equity
1,164940.38276.54173.7779.82
Total Debt
467.11360.1611.887.111.85
Net Cash (Debt)
-325.2479.8472.0772.0514.17
Net Cash Growth
-10.78%0.02%408.42%-75.70%
Net Cash Per Share
-0.960.230.220.230.05
Book Value
415.38352.94101.4454.441.57
Book Value Per Share
1.231.020.310.180.01
Tangible Book Value
-177.4595.0826.7414.31-38.94
Tangible Book Value Per Share
-0.530.280.080.05-0.14
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q